ArticleVeterinary research2026
EZH2 enhances PCV2 replication through inhibition of MMP1 and MMP12 transcription activity.
Article in Veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Porcine circovirus type 2 (PCV2), a single-stranded circular DNA virus, primarily targets the porcine immune system. It induces immunosuppression, subsequent porcine circovirus disease (PCVAD), causing substantial economic losses to the global swine industry. Enhancer of zeste homolog 2 (EZH2), a critical member of the polycomb group (PcG) protein family with histone methyltransferase activity, plays a significant role in epigenetic regulation. While previous studies have established EZH2's role in viral infection and innate immune responses, its function in PCV2 infection remains unclear. In this study, we found that EZH2 overexpression promoted PCV2 infection, whereas EZH2 knockdown via specific small interfering RNA (siRNA) and inhibition of its activity reduced PCV2 infection. Furthermore, we identified EZH2-regulated downstream genes by RNA sequencing (RNA-seq) and found that MMP1 and MMP12 were significantly upregulated when EZH2 methyltransferase activity was inhibited by GSK126. Mechanistically, EZH2 overexpression repressed the promoters of MMP1 and MMP12, thereby facilitating PCV2 replication. Conversely, upon depletion of the EZH2 methyltransferase domain, inhibition of MMP1 and MMP12 promoters is lifted, thereby enabling MMP1 and MMP12 to suppress PCV2 replication. Our findings establish a link between the histone methyltransferase EZH2 and the PCV2 life cycle, advance understanding of the mechanisms underlying PCV2 infection, and suggest that drugs targeting MMP1/MMP12 activity may provide potential therapeutic approaches to prevent and control PCV2 infection and spread.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.